These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 29278442

  • 1. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
    Xiao X, Liu Y, Zhong X, Liu Y, Zhou D, Xiong X, Ran J.
    Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
    [Abstract] [Full Text] [Related]

  • 2. Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency.
    Nagano N, Miyata S, Obana S, Ozai M, Kobayashi N, Fukushima N, Burke SK, Wada M.
    Nephrol Dial Transplant; 2001 Sep; 16(9):1870-8. PubMed ID: 11522872
    [Abstract] [Full Text] [Related]

  • 3. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.
    Nagano N, Miyata S, Obana S, Kobayashi N, Abe M, Fukushima N, Wada M.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii81-5. PubMed ID: 12771309
    [Abstract] [Full Text] [Related]

  • 4. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency.
    Nagano N, Miyata S, Abe M, Wakita S, Kobayashi N, Wada M.
    Nephrol Dial Transplant; 2006 Mar; 21(3):634-43. PubMed ID: 16169864
    [Abstract] [Full Text] [Related]

  • 5. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
    Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E.
    J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
    [Abstract] [Full Text] [Related]

  • 6. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E.
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
    Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N.
    Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proliferative activity of the parathyroid cells in rats with secondary hyperparathyroidism.
    Yamaguchi S, Yachiku S, Hashimoto H, Okuyama M, Tsurukawa H, Kawakami N, Watabe Y, Sue Y.
    Virchows Arch; 2001 Apr; 438(4):388-93. PubMed ID: 11355174
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.
    Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld AJ.
    Bone; 1999 Sep; 25(3):279-85. PubMed ID: 10495131
    [Abstract] [Full Text] [Related]

  • 14. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
    Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 17. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
    Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, Fukushima S, Fujimori A, Itoh H, Okada M.
    Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
    [Abstract] [Full Text] [Related]

  • 18. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
    Chen XJ, Chen X, Wu WJ, Zhou Q, Gong XH, Shi BM.
    J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
    [Abstract] [Full Text] [Related]

  • 19. PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
    Yaguchi A, Tatemichi S, Takeda H, Kobayashi M.
    PLoS One; 2017 Sep; 12(7):e0180430. PubMed ID: 28704404
    [Abstract] [Full Text] [Related]

  • 20. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
    Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, Akiba T, Nitta K.
    Nephron Clin Pract; 2008 Sep; 108(4):c278-83. PubMed ID: 18434749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.